Information Provided By: 
Fly News Breaks for October 24, 2018
CNC
Oct 24, 2018 | 07:57 EDT
As previously reported, Leerink analyst Ana Gupte upgraded Centene to Outperform from Market Perform and raised her price target on the shares to $155 from $130. The analyst sees the margin risks that have kept her on the sidelines finally priced in the stock after a soft 2018 performance year to date. Gupte is encouraged by "the blessing of consensus 2019E EPS on the Q3 commentary," and expects that revenues could even exceed $69B, offsetting potential for margin compression.
News For CNC From the Last 2 Days
CNC
Apr 15, 2024 | 10:37 EDT
Shares of health care facilities and managed care are in the spotlight on Monday after Florida announced late on Friday five winners of six-year Medicaid managed care contracts. Among the winners... To see the rest of the story go to thefly.com. See Story Here
CNC
Apr 15, 2024 | 09:56 EDT
CNC
Apr 15, 2024 | 09:47 EDT
CNC
Apr 15, 2024 | 06:16 EDT
CNC
Apr 15, 2024 | 06:15 EDT
Wells Fargo raised the firm's price target on Centene (CNC) to $93 from $89 and keeps an Overweight rating on the shares. The firm notes Florida intends to award Medicaid contracts to Centene, Elevance Health (ELV), Humana (HUM) and two provider-run plans. Clearly the most positive for Centene given recent disappointing RFP performance and likely most disappointing for Molina Healthcare (MOH) given expectation for share gains, Wells says.
